NCT03649334View on ClinicalTrials.gov

Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 26, 2018

Primary Completion Date

October 1, 2018

Study Completion Date

October 15, 2018

Conditions
Hematological Malignancy (Leukemia- Lymphoma)
Interventions
DRUG

ketamine-ketorolac

The patient will receive ketamine 0.5mg.kg-1 + ketorolac 1mk.kg-1 in 2 ml syringe intramuscularly.

DRUG

fentanyl- ketorolac

The patient will receive fentanyl 1.5ug.kg-1 + ketorolac 1 mg.kg-1 in 2ml syringe intramuscularly

Trial Locations (1)

050

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03649334 - Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy | Biotech Hunter | Biotech Hunter